鼠李糖乳桿菌 GG Lactobacillus rhamnosus GG (LGG) × 齲齒
結論：證據支持但有警示
Strain-exact 證據存在但有限：Nase 2001 RCT (n=594, 7 個月) 為唯一明確使用 LGG 單株並顯示顯著齲齒風險降低 (OR=0.
B 🟡 B 初步證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
Strain-exact 證據存在但有限：Nase 2001 RCT (n=594, 7 個月) 為唯一明確使用 LGG 單株並顯示顯著齲齒風險降低 (OR=0.56, p=0.01) 的長期研究，且 EFSA 明確列名 LGG (ATCC 53103) 與牙齒礦化宣稱 (ID 3018) 進行審查（雖最終判定因果關係未建立而拒絕）。
2023–2025 系統性回顧雖支持 L. rhamnosus 為對學齡前兒童最有效菌種，但多為 species-level 證據或 LGG+L. paracasei+arginine 複方研究，難以分離 LGG 單獨效益；ADA/IADR/Mayo/Cleveland/Harvard 等主流醫療與牙科機構均未將 LGG 納入齲齒預防臨床建議。
給予 B 等級反映：strain-exact RCT 存在但證據基礎窄（單一里程碑試驗 + 混合複方研究），且最權威監管/學會立場 (EFSA, ADA) 為 cautious/未推薦。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.67
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
76%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.67
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children
— 詳細結論請見 PubMed 原文
前往 PubMed
Can probiotics prevent dental caries? (systematic review & meta-analysis)
— 詳細結論請見 PubMed 原文
前往 PubMed
Effect of Probiotics Lactobacillus rhamnosus and Lactobacillus plantarum on Caries and Periodontal Diseases: A Systematic Review
— 詳細結論請見 PubMed 原文
前往 PubMed
The role of probiotics in preventing dental caries: a systematic review of clinical evidence
— 詳細結論請見 PubMed 原文
前往 PubMed
Unlocking the potential of probiotic administration in caries management: a systematic review
— 詳細結論請見 PubMed 原文
前往 PubMed
L4a US FDA
支持
GRN No. 231 — Notified Substance: Lactobacillus casei subsp. rhamnosus strain GG. Intended Use: Ingredient in term infant formula, at levels not to exceed 10^8 colony forming units per gram of powdered formula. Notifier: Mead Johnson & Company. Agency Response: FDA has no questions (closure date: May 29, 2008). 來源↗
L4b EU EFSA
謹慎
The bacterial species L. rhamnosus (now Lacticaseibacillus rhamnosus) is considered by EFSA to be suitable for the qualified presumption of safety (QPS) approach to safety assessment. However, the EFSA Panel on Dietetic Products, Nutrition and Allergies concluded that a cause and effect relationship has not been established between the consumption of Lactobacillus rhamnosus GG (ATCC 53103, LGG)… 來源↗
L4c UK NHS
中性
Probiotics are generally classed as food rather than medicine, which means they don't go through the rigorous testing medicines do. ... For most people, probiotics appear to be safe. If you want to try them, and you have a healthy immune system, they shouldn't cause any unpleasant side effects. ... If you have an existing health condition or a weakened immune system, you should talk to a doctor… 來源↗
L4d TW TFDA / 衛福部
支持
Lactobacillus rhamnosus is listed in the 'Food Ingredients Available for Use' (可供食品使用原料) comprehensive list as a lactic acid bacterium (乳酸菌), in the form of bacterial cells (菌體), and can be used as a food ingredient or for food processing purposes. 來源↗
L4e WHO
支持
Administration of Lacticaseibacillus rhamnosus GG (LGG) to children with gastroenteritis is recommended by universal guidelines. The World Gastroenterology Organisation's Global Guidelines for Probiotics and Prebiotics (2023 update) lists LGG as having documented, positive results in multiple gut-related health areas. The FAO/WHO Joint Working Group (London, Ontario, 2002) 'Guidelines for the E… 來源↗
L5a NIH Office of Dietary Supplements
支持
Lactobacillus rhamnosus GG is an example where Lactobacillus is the genus, rhamnosus is the species, and GG is the strain. Treatment with LGG compared with placebo or no additional treatment reduced the risk of antibiotic-associated diarrhea in patients treated with antibiotics from 22.4% to 12.3% (relative risk: 0.49). However, when children and adults were evaluated separately, the difference… 來源↗
L5b Mayo Clinic
中性
— 本適應症無對應資料
L5c Cleveland Clinic
中性
— 本適應症無對應資料
L5d Harvard Health
中性
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
中性
— 本適應症無對應資料
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
台灣 PTT、Dcard、Mobile01、BabyHome 等社群幾乎找不到「LGG/Culturelle」具名針對「齲齒/蛀牙」的個人經驗分享；齲齒相關討論多聚焦於潔牙、含氟、木糖醇與雷特氏菌（L. reuteri）等口腔益生菌，而 Culturelle 的台灣討論多集中在腹瀉、過敏、免疫等議題，並非牙齒保健。少數提到 LGG 可降低變形鏈球菌的內容多來自品牌部落格或保健品電商頁（heho、vocus、forward-finder、vitabox），屬於行銷文而非真實社群口碑，廣告污染明顯。
💬社群實感
資料不足
破解迷思 社群最常見的 3 個誤解
✓
事實誤以為所有「益生菌」都能預防蛀牙，未區分腸道菌株（LGG）與口腔菌株（如 L. reuteri、L. paracasei SD1）
✓
事實把品牌部落格行銷文當成真實使用者心得，認為 Culturelle 對牙齒有直接保健作用
✓
事實誤認為吃益生菌可取代刷牙、含氟、定期洗牙等基礎口腔護理
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- Culturelle 康萃樂
- BioGaia 拜奧（L. reuteri，常被討論用於蛀牙/口腔）
- 達摩本草
- 好聰敏
- 養樂多 Yakult
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳
葡萄王LGG特益菌 — 許可證字號：衛署健食字第A00028號，功效：有助於增加腸內乳酸菌菌數。主要成分為乳酸菌凍乾品 (Lactobacillus rhamnosus GG)。
代表來源 ↗ L10b · TFDA 法定身份 官方認定
✅健康食品（小綠人）
鼠李糖乳酸桿菌（Lactobacillus rhamnosus）被列為微生物及其來源製取之原料，其菌體可供為食品原料或食品加工使用。在台灣，益生菌基本上歸類為「食品」，由食藥署（TFDA）管理，主要規範標示與安全性，避免虛假功效宣稱。若產品要宣稱「輔助調整過敏體質」或「改善胃腸功能」等保健功效，必須通過審查並取得健康食品（小綠人）標章。
來源 ↗- 氟化物（牙膏、含漱、塗氟）
- 減糖 + 規律刷牙
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-dental-caries-INT-lactobacillus-rhamnosus-gg-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "鼠李糖乳桿菌 GG能改善齲齒",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}